These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 9466083)

  • 21. Combination sodium sulfacetamide 10% and sulfur 5% cream with sunscreens versus metronidazole 0.75% cream for rosacea.
    Torok HM; Webster G; Dunlap FE; Egan N; Jarratt M; Stewart D
    Cutis; 2005 Jun; 75(6):357-63. PubMed ID: 16047874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosacea.
    Wolf JE; Kerrouche N; Arsonnaud S
    Cutis; 2006 Apr; 77(4 Suppl):3-11. PubMed ID: 16706244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of a novel rosacea treatment system: an investigator-blind, randomized, parallel-group study.
    Leyden JJ
    J Drugs Dermatol; 2011 Oct; 10(10):1179-85. PubMed ID: 21968669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The CLEAR trial: results of a large community-based study of metronidazole gel in rosacea.
    Wolf JE; Del Rosso JQ
    Cutis; 2007 Jan; 79(1):73-80. PubMed ID: 17330626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The efficacy of metronidazole 1% cream once daily compared with metronidazole 1% cream twice daily and their vehicles in rosacea: a double-blind clinical trial.
    Jorizzo JL; Lebwohl M; Tobey RE
    J Am Acad Dermatol; 1998 Sep; 39(3):502-4. PubMed ID: 9738794
    [No Abstract]   [Full Text] [Related]  

  • 26. A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea.
    Maddin S
    J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):961-5. PubMed ID: 10365928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Double-blind, randomized, vehicle-controlled clinical trial of once-daily benzoyl peroxide/clindamycin topical gel in the treatment of patients with moderate to severe rosacea.
    Breneman D; Savin R; VandePol C; Vamvakias G; Levy S; Leyden J
    Int J Dermatol; 2004 May; 43(5):381-7. PubMed ID: 15117375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pimecrolimus cream 1% for papulopustular rosacea: a randomized vehicle-controlled double-blind trial.
    Weissenbacher S; Merkl J; Hildebrandt B; Wollenberg A; Braeutigam M; Ring J; Hofmann H
    Br J Dermatol; 2007 Apr; 156(4):728-32. PubMed ID: 17493072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind study of I% metronidazole cream versus systemic oxytetracycline therapy for rosacea.
    Nielsen PG
    Br J Dermatol; 1983 Jul; 109(1):63-5. PubMed ID: 6222756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adapalene vs. metronidazole gel for the treatment of rosacea.
    Altinyazar HC; Koca R; Tekin NS; Eştürk E
    Int J Dermatol; 2005 Mar; 44(3):252-5. PubMed ID: 15807740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metronidazole in the treatment of rosacea: do formulation, dosing, and concentration matter?
    Yoo J; Reid DC; Kimball AB
    J Drugs Dermatol; 2006 Apr; 5(4):317-9. PubMed ID: 16673797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical metronidazole for severe and recalcitrant rosacea: a prospective open trial.
    Lowe NJ; Henderson T; Millikan LE; Smith S; Turk K; Parker F
    Cutis; 1989 Mar; 43(3):283-6. PubMed ID: 2523290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized, single-blind, placebo-controlled, split-face study with pimecrolimus cream 1% for papulopustular rosacea.
    Karabulut AA; Izol Serel B; Eksioglu HM
    J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):729-34. PubMed ID: 18328059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of metronidazole 1% cream and pimecrolimus 1% cream in the treatment of patients with papulopustular rosacea: a randomized open-label clinical trial.
    Koca R; Altinyazar HC; Ankarali H; Muhtar S; Tekin NS; Cinar S
    Clin Exp Dermatol; 2010 Apr; 35(3):251-6. PubMed ID: 19594764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the First REVEAL Trial.
    Kircik LH; DuBois J; Draelos ZD; Werschler P; Grande K; Cook-Bolden FE; Weng E; Berk DR; Ahluwalia G
    J Drugs Dermatol; 2018 Jan; 17(1):97-105. PubMed ID: 29320594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new formulation containing sunscreen (SPF 15) and 1% metronidazole (ROSASOL Cream) in the treatment of rosacea.
    Tan JK
    Skin Therapy Lett; 2001 May; 6(8):1-2. PubMed ID: 11438812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea.
    Del Rosso JQ; Webster GF; Jackson M; Rendon M; Rich P; Torok H; Bradshaw M
    J Am Acad Dermatol; 2007 May; 56(5):791-802. PubMed ID: 17367893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical metronidazole combination therapy in the clinical management of rosacea.
    Del Rosso JQ; Bikowski J
    J Drugs Dermatol; 2005; 4(4):473-80. PubMed ID: 16004021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical metronidazole for rosacea.
    Gupta AK; Chaudhry M
    Skin Therapy Lett; 2002 Jan; 7(1):1-3, 6. PubMed ID: 11859387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized placebo-controlled trial of a flavonoid-rich plant extract-based cream in the treatment of rosacea.
    Rigopoulos D; Kalogeromitros D; Gregoriou S; Pacouret JM; Koch C; Fisher N; Bachmann K; Brown M; Schwarz E; Camel E; Katsambas A
    J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):564-8. PubMed ID: 16164709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.